Drugs / dHACM
dHACM
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial | ||||||
| Phase 3 | NCT03414268 | Jan 2018 → Mar 2021 | plantar fasciitis | MiMedx Group, Inc. | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT04417140 | May 2020 → May 2022 | — | Louisiana State University Health Sciences Center in New Orleans | Unknown | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | dHACM | “Micronized dehydrated human amnion/chorion membrane (dHACM)” NCT03414268 ↗ |
| Known as | AmnioWrap | “dHACM (AmnioWrap)” NCT04417140 ↗ |
| Known as | Dehydrated human amnion-chorion membrane | “Dehydrated human amnion-chorion membrane (dHACM) is a healing adjunct” NCT04417140 ↗ |
| Known as | Dehydrated Human Amniotic-Chorion Membrane | “dHACM is Dehydrated Human Amniotic-Chorion Membrane.” NCT04417140 ↗ |
| Modality | Other / unclassified | “Dehydrated human amnion-chorion membrane (dHACM) is a healing adjunct” NCT04417140 ↗ |